NASDAQ:RNAZ | EBITDA | Transcode Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical EBITDA

DateEBITDA
2026-06-30-$6.77M
2026-03-31-$17.73M
2025-12-31-$15.98M
2025-09-30-$4.56M
2025-06-30-$4.21M
2025-03-31-$3.16M
2024-12-31-$5.08M
2024-09-30-$2.15M
2024-06-30-$5.08M
2024-03-31-$3.26M
2023-12-31-$4.07M
2023-09-30-$5.28M
2023-06-30-$5.09M
2023-03-31-$4.86M
2022-12-31-$5.47M
2022-09-30-$4.93M
2022-06-30-$4.68M
2022-03-31-$3.46M
2021-12-31-$2.96M
2021-03-31-$448,211.00

Annual EBITDA

DateEBITDA
2025-12-31-$27.9M
2024-12-31-$15.57M
2023-12-31-$19.3M
2022-12-31-$18.54M
2021-12-31-$6.11M
2020-12-31-$726,604.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.